170 related articles for article (PubMed ID: 23137668)
1. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.
Kaur G; Kane AJ; Sughrue ME; Oh M; Safaee M; Sun M; Tihan T; McDermott MW; Berger MS; Parsa AT
J Clin Neurosci; 2013 Jan; 20(1):89-93. PubMed ID: 23137668
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience.
Byun J; Hong SH; Yoon MJ; Kwon SM; Cho YH; Kim JH; Kim CJ
J Neurooncol; 2018 Dec; 140(3):669-677. PubMed ID: 30225773
[TBL] [Abstract][Full Text] [Related]
4. Atypia predicting prognosis for intracranial extraventricular neurocytomas.
Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Lehil M; Fang S; Parsa AT
J Neurosurg; 2012 Feb; 116(2):349-54. PubMed ID: 22054208
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
[TBL] [Abstract][Full Text] [Related]
6. Atypical central neurocytoma.
Söylemezoglu F; Scheithauer BW; Esteve J; Kleihues P
J Neuropathol Exp Neurol; 1997 May; 56(5):551-6. PubMed ID: 9143268
[TBL] [Abstract][Full Text] [Related]
7. Central neurocytoma with unusually high MIB-1 index.
Ide M; Hagiwara S; Kawamura H; Aiba M
Acta Neurochir (Wien); 2006 Nov; 148(11):1217-8. PubMed ID: 16955227
[No Abstract] [Full Text] [Related]
8. Ventricular Central Neurocytoma: Rate of Shunting and Outcome 2 Years After Total and Subtotal Excision.
Soliman WS
Acta Neurochir Suppl; 2017; 124():179-185. PubMed ID: 28120072
[TBL] [Abstract][Full Text] [Related]
9. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
10. Atypical Central Neurocytoma: An Investigation of Prognostic Factors.
AbdelBari Mattar M; Shebl AM; Toson EA
World Neurosurg; 2021 Feb; 146():e184-e193. PubMed ID: 33091649
[TBL] [Abstract][Full Text] [Related]
11. Central neurocytomas.
Schild SE; Scheithauer BW; Haddock MG; Schiff D; Burger PC; Wong WW; Lyons MK
Cancer; 1997 Feb; 79(4):790-5. PubMed ID: 9024717
[TBL] [Abstract][Full Text] [Related]
12. Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence.
Ito E; Saito K; Okada T; Nagatani T; Nagasaka T
Acta Neurochir (Wien); 2010 Jan; 152(1):57-67; discussion 67. PubMed ID: 19826755
[TBL] [Abstract][Full Text] [Related]
13. Solitary fibrous tumor of the central nervous system: a clinicopathologic study of 24 cases.
Chen H; Zeng XW; Wu JS; Dou YF; Wang Y; Zhong P; Xu R; Jiang CC; Wang XQ
Acta Neurochir (Wien); 2012 Feb; 154(2):237-48; discussion 248. PubMed ID: 21938461
[TBL] [Abstract][Full Text] [Related]
14. A study of prognostic factors in 45 cases of atypical meningioma.
Endo T; Narisawa A; Ali HS; Murakami K; Watanabe T; Watanabe M; Jokura H; Endo H; Fujimura M; Sonoda Y; Tominaga T
Acta Neurochir (Wien); 2016 Sep; 158(9):1661-7. PubMed ID: 27468919
[TBL] [Abstract][Full Text] [Related]
15. Role of endoscopic transnasal surgery for skull base chondrosarcoma: a retrospective analysis of 19 cases at a single institution.
Hasegawa H; Shin M; Kondo K; Hanakita S; Mukasa A; Kin T; Saito N
J Neurosurg; 2018 May; 128(5):1438-1447. PubMed ID: 28686110
[TBL] [Abstract][Full Text] [Related]
16. Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling index.
Uehara K; Sasayama T; Miyawaki D; Nishimura H; Yoshida K; Okamoto Y; Mukumoto N; Akasaka H; Nishihara M; Fujii O; Soejima T; Sugimura K; Kohmura E; Sasaki R
Radiat Oncol; 2012 Jun; 7():104. PubMed ID: 22734595
[TBL] [Abstract][Full Text] [Related]
17. [Central neurocytomas: long-term treatment outcomes].
Konovalov AN; Maryashev SA; Pitskhelauri DI; Golanov AV; Pronin IN; Dalechina AV; Ryzhova MV; Antipina NA
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(2):5-16. PubMed ID: 33864664
[TBL] [Abstract][Full Text] [Related]
18. Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination.
Ogawa Y; Sugawara T; Seki H; Sakuma T
J Neurooncol; 2006 Sep; 79(2):211-6. PubMed ID: 16552620
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection.
Fukuda M; Oishi M; Hiraishi T; Natsumeda M; Fujii Y
J Neurosurg; 2011 May; 114(5):1224-31. PubMed ID: 21214329
[TBL] [Abstract][Full Text] [Related]
20. Central neurocytoma: 9 case series and review.
Chen CM; Chen KH; Jung SM; Hsu HC; Wang CM
Surg Neurol; 2008 Aug; 70(2):204-9. PubMed ID: 18262625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
